Study identifies cognitive benefits of ketamine in patients with treatment-resistant depression
This article is based on the results of “Evaluation of Early Ketamine Effects on Belief-Updating Biases in Patients With Treatment-Resistant Depression”, recently published in JAMA Psychiatry. The article was originally published on The Conversation and translated from the French by Enda Boorman for Fast ForWord.
To Learn More:
FDA-approved, Cybin-sponsored clinicial trial to measure ketamine’s impact on the brain via Kernel Flow neuroimaging helmet
Study: Psychedelics can promote neural plasticity in the prefrontal cortex and expand pathways for mental health
The post Study identifies cognitive benefits of ketamine in patients with treatment-resistant depression appeared first on SharpBrains.
Source: SharpBrains - Category: Neuroscience Authors: The Conversation Tags: Brain/ Mental Health affective bias antidepressants augmented psychotherapy brain-activity Brain-Plasticity Cognitive Neuroscience depression depressive beliefs ketamine NMDA pharmacological psilocybin psychedelic medicine psyc Source Type: blogs
More News: Accidents | Back Pain | Brain | Depression | Drugs & Pharmacology | Environmental Health | France Health | International Medicine & Public Health | Learning | Men | Neurology | Neuroscience | Pain | Psychiatry | Psychotherapy | Schizophrenia | Statistics | Study | Suicide | Universities & Medical Training | WHO